Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues medicines CEO Lars Fruergaard Jørgensen advised lawmakers the business would take into consideration new talks with insurers about the record costs of Wegovy and copyright whenever they pledge to maintain the medicines on their own formularies. Sanders https://label-the-figure-with-the83827.timeblog.net/66468462/5-simple-techniques-for-healthcare-news